Template:Sodium channel blocking toxidromes: Difference between revisions
No edit summary |
|||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
===Sodium Channel | ===Sodium Channel Blockade Toxidrome=== | ||
*Phenothiazines | |||
*Antihistamines | |||
*Sotalol | |||
* | *[[Tricyclic antidepressant (TCA) toxicity|TCAs]] | ||
*Antipsychotics | |||
* | *[[Cocaine toxicity|Cocaine]] | ||
*Anti-spasmodics, cyclobenzaprine | |||
*Chloroquine | |||
*Anti-malarials | |||
*Class Ia and Ic antiarrhythmics | |||
*[[Local anesthetic systemic toxicity]] | |||
*[[Venlafaxine]] toxicity | |||
Latest revision as of 13:56, 1 September 2019
Sodium Channel Blockade Toxidrome
- Phenothiazines
- Antihistamines
- Sotalol
- TCAs
- Antipsychotics
- Cocaine
- Anti-spasmodics, cyclobenzaprine
- Chloroquine
- Anti-malarials
- Class Ia and Ic antiarrhythmics
- Local anesthetic systemic toxicity
- Venlafaxine toxicity
